News | September 29, 2009

EARLY Act Legislation for Breast Cancer Prevention Gains Momentum

EARLY Act Legislation for Breast Cancer Prevention Gains Momentum

Gail Lebovic, M.D., president of the American Society of Breast Disease

September 29, 2009 - The campaign to pass the EARLY Act and raise awareness about breast cancer in young adult women generated momentum at a recent congressional reception on Capitol Hill.

The EARLY Act would implement a national education campaign about the risks that young adult women (under 45) face from breast cancer. The bill, with $9 million per year in proposed funding for five years, would also provide assistance to young women who have the disease.

The legislation has generated widespread support both in Congress and from national organizations, including the Susan G. Komen Foundation and Breast Cancer Network of Strength (formerly Y-Me). The legislation has over 365 cosponsors in the House of Representatives and over 30 in the Senate.

Kathryn Tunstall, former chairman of the Board and currently chair of the clinical advisory panel of NeoMatrix, told the audience that her experience as a two-time breast cancer survivor had inspired her to take a leadership role at NeoMatrix. The company provides the HALO Breast Pap Test, a new, 5-minute, noninvasive test that helps determine an individual woman's risk of developing breast cancer.

As part of its support for the EARLY Act, NeoMatrix has launched a website, www.earlyactawareness.org, that educates viewers about the EARLY Act and breast cancer risk. The site provides details on the EARLY Act and the breast cancer risks faced by younger women. It also has tools for breast cancer risk assessment and prevention, including information about HALO.

Also speaking at the Congressional Reception, which was organized by the nonprofit Tigerlily Foundation and cosponsored by NeoMatrix, was Gail Lebovic, M.D., president of the American Society of Breast Disease.

The Capitol Hill event, which drew approximately 200 people, was held in the Rayburn building of the House of Representatives immediately before Pres. Obama’s speech to the Congress on healthcare reform. Among other speakers at the Tigerlily event were Rep. Debbie Wasserman Schultz (D.-Fla.), author of the legislation; Rep. Sue Myrick (R.-N.C.) and Rep. Jackie Speier (D.-Calif.).

For more information: www.earlyactawareness.org and www.asbd.org

Related Content

#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to d
In looking at the broader impact of the COVID-19 pandemic on health and wellbeing, public health experts are examining screening rates for cancer. A new study looking at U.S. mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — In looking at the broader impact of the...